‹ All Posts
Shrikant Pandey

6th Nov · SEBI Registration INH000023986

ANUPAM RASAYAN Q2 FY27: SIGNS 6-YEAR US SUPPLY AGREEMENT

ANUPAM RASAYAN Q2 FY27: SIGNS 6-YEAR US SUPPLY AGREEMENT; ACQUIRES 50.07% STAKE IN BLISS GVS PHARMA ANURAS • New US Supply Agreement: Signed a six-year long-term supply agreement with a US-based specialty metal manufacturer, marking its entry into the geological resources sector. • Strategic Acquisition: Completed the acquisition of a 50.07% controlling stake in Bliss GVS Pharma, strengthening its presence in the pharmaceutical sector. • Pharmaceutical Expansion: The acquisition adds finished dosage formulation capabilities, enabling Anupam Rasayan to expand its presence across the pharmaceutical value chain. • Global Customer Expansion: The company remains focused on deepening relationships with existing international customers while entering new applications and end markets. • Business Diversification: Strengthening its capabilities across Pharmaceuticals, Performance Materials and other specialised chemical segments. • Acquisition Synergies: Management expects operational and commercial synergies from integrating Bliss GVS Pharma with its existing businesses. • Manufacturing Strategy: Focused on optimising capital utilisation and continuously improving manufacturing efficiency and technological capabilities. • Future Growth Strategy: Aims to build a globally integrated specialty chemicals and pharmaceutical platform through strategic investments, new applications and customer diversification.

#WatchOutFor
1,375 likes·65 comments